Solana Biofuels Limited
Southern Online Bio Technologies the name of the Company has been Changed to Southern Online Bio Technologies Limited on 31st March 2004 to reflect the new line of business in which the Company has ventured i.e. manufacture of Biodiesel. Currently the Companys shares are listed at BSE.
- Market Cap ₹ 5.49 Cr.
- Current Price ₹ 0.93
- High / Low ₹ /
- Stock P/E 9.63
- Book Value ₹ 11.1
- Dividend Yield 0.00 %
- ROCE 0.87 %
- ROE 0.93 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.08 times its book value
- Company's working capital requirements have reduced from 274 days to 111 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -60.4% over past five years.
- Company has high debtors of 276 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
60.83 | 91.24 | 143.07 | 201.40 | 246.95 | 220.85 | 123.65 | 6.40 | 2.09 | 2.14 | 2.68 | |
55.29 | 101.21 | 135.34 | 200.82 | 247.63 | 220.77 | 154.82 | 106.91 | 81.08 | 1.49 | 1.68 | |
Operating Profit | 5.54 | -9.97 | 7.73 | 0.58 | -0.68 | 0.08 | -31.17 | -100.51 | -78.99 | 0.65 | 1.00 |
OPM % | 9.11% | -10.93% | 5.40% | 0.29% | -0.28% | 0.04% | -25.21% | -1,570.47% | -3,779.43% | 30.37% | 37.31% |
0.04 | 0.27 | 0.28 | 0.08 | 0.20 | 0.50 | 0.44 | 2.67 | 334.57 | 0.07 | 0.00 | |
Interest | 7.84 | 16.81 | 11.33 | 18.32 | 19.71 | 6.23 | 33.56 | 23.08 | 0.11 | 0.02 | 0.01 |
Depreciation | 4.72 | 7.08 | 2.72 | 7.61 | 11.96 | 1.77 | 10.59 | 10.11 | 9.80 | 0.21 | 0.38 |
Profit before tax | -6.98 | -33.59 | -6.04 | -25.27 | -32.15 | -7.42 | -74.88 | -131.03 | 245.67 | 0.49 | 0.61 |
Tax % | 53.01% | 6.91% | 59.27% | -32.45% | -63.64% | -32.48% | 0.67% | 2.21% | 32.50% | 8.16% | |
-10.68 | -35.91 | -9.62 | -17.07 | -11.70 | -5.01 | -75.38 | -133.92 | 165.82 | 0.46 | 0.57 | |
EPS in Rs | -3.09 | -10.37 | -2.78 | -3.33 | -1.98 | -0.85 | -12.78 | -22.70 | 28.11 | 0.10 | 0.12 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -28% |
5 Years: | -60% |
3 Years: | -31% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 16% |
3 Years: | 26% |
TTM: | -100% |
Stock Price CAGR | |
---|---|
10 Years: | -17% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 34.61 | 34.61 | 34.61 | 51.28 | 58.99 | 58.99 | 58.99 | 58.99 | 0.00 | 45.00 |
Reserves | 22.91 | -6.76 | -6.54 | -31.98 | -51.45 | -56.47 | -131.85 | -265.77 | 49.45 | 4.90 |
92.78 | 118.96 | 137.27 | 143.60 | 184.18 | 243.46 | 339.86 | 340.32 | 7.88 | 9.87 | |
33.74 | 23.51 | 38.42 | 54.31 | 71.29 | 76.45 | 18.66 | 35.75 | 4.16 | 6.48 | |
Total Liabilities | 184.04 | 170.32 | 203.76 | 217.21 | 263.01 | 322.43 | 285.66 | 169.29 | 61.49 | 66.25 |
125.27 | 118.57 | 130.20 | 125.72 | 111.51 | 137.51 | 129.20 | 118.14 | 51.73 | 51.58 | |
CWIP | 0.46 | 1.51 | 0.46 | 0.50 | 3.03 | 0.57 | 0.60 | 0.60 | 0.46 | 4.01 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
58.31 | 50.24 | 73.10 | 90.99 | 148.47 | 184.35 | 155.86 | 50.55 | 9.30 | 10.66 | |
Total Assets | 184.04 | 170.32 | 203.76 | 217.21 | 263.01 | 322.43 | 285.66 | 169.29 | 61.49 | 66.25 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
10.22 | -27.11 | -16.34 | -13.44 | -45.15 | -35.34 | -96.44 | 0.80 | 274.34 | 2.34 | |
-41.66 | -1.44 | -13.29 | -2.86 | -0.34 | -25.30 | -2.32 | 0.95 | 45.56 | -3.61 | |
30.66 | 32.43 | 28.15 | 20.13 | 40.72 | 60.63 | 97.58 | -1.66 | -320.19 | 2.13 | |
Net Cash Flow | -0.78 | 3.88 | -1.48 | 3.83 | -4.78 | -0.01 | -1.18 | 0.08 | -0.29 | 0.86 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23.82 | 61.93 | 96.18 | 65.10 | 64.56 | 110.42 | 306.73 | 280.59 | 296.89 | 276.31 |
Inventory Days | 289.61 | 52.74 | 66.91 | 73.31 | 52.79 | 92.55 | 22.38 | 641.90 | ||
Days Payable | 32.10 | 29.31 | 61.57 | 91.90 | 107.48 | 121.97 | 26.47 | 756.57 | ||
Cash Conversion Cycle | 281.34 | 85.36 | 101.52 | 46.51 | 9.87 | 81.00 | 302.64 | 165.92 | 296.89 | 276.31 |
Working Capital Days | 271.93 | 110.49 | 108.20 | 60.97 | 84.44 | 139.26 | 366.68 | 165.96 | 436.60 | 110.86 |
ROCE % | -11.30% | 3.39% | -4.22% | -6.89% | -0.54% | -16.11% | -53.79% | 0.87% |
Documents
Announcements
-
Closure of Trading Window
28 Jun - Trading window closed from July 1, 2025, till 48 hours after June 30 quarter results announcement.
-
Board Meeting Outcome for Outcome Of Board Meeting
29 May - Solana Biofuels reports FY25 audited loss of Rs.111.12 lakhs; auditors give unmodified opinion.
-
Financial Results For The Period Ended 31.03.2025
29 May - Solana Biofuels reports FY25 audited results: Rs.14,742L revenue, Rs.111L net loss, auditor unmodified opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
24 May - Annual Secretarial Compliance Report submitted for year ended March 31, 2025.
-
Board Meeting Intimation for To Consider And Approve The Audited Financial Results
22 May - Board meeting on May 29 to approve FY25 Q4 and annual audited financial results.